Affiliation
Coventry and Warwickshire Partnership Trust; Institute for Mind and Brain in Kerala; Keele University Medical School; Midlands Partnership NHS Foundation TrustPublication date
2020-06-11Subject
Mental healthPharmacology
Diseases & disorders of systemic, metabolic or environmental origin
Metadata
Show full item recordAbstract
Advocating for good physical healthcare for their patients is of the utmost importance to psychiatrists. This narrative review focuses on one part of this large goal, the topic of hyperprolactinaemia from the perspective of mental healthcare. For psychiatrists this often includes managing raised prolactin levels in the context of medication. However, they must consider the wider differentials of a raised prolactin level and the possible impact of treatments. For that reason, in this review we start with an overview of prolactin physiology before considering hyperprolactinaemia both in the context of antipsychotic therapy and its wider differentials, including prolactinoma. Investigation and management are considered and key practice points developed.Citation
Romain K, Fynes-Clinton S, Harmer D, Kumar M. Hyperprolactinaemia in the context of psychiatry. BJPsych Advances. 2021;27(1):26-37. doi:10.1192/bja.2020.36Type
ArticleAdditional Links
https://www.cambridge.org/core/journals/bjpsych-advances/article/hyperprolactinaemia-in-the-context-of-psychiatry/737DE2EEA52E1424DD5D128E040BF75CJournal
BJPsych AdvancesPublisher
Cambridge University Pressae974a485f413a2113503eed53cd6c53
10.1192/bja.2020.36